BGI

37 articles about BGI

• BGI Australia Receives NATA Certification for Clinical Whole Exome Sequencing

  10/20/2022

  BGI Australia's lab has achieved accreditation from the National Association of Testing Authorities to perform clinical Whole Exome Sequencing in Australia, paving the way for the global life sciences company to provide clinical sequencing services for identifying possible disease-causing genetic changes.

• Sinai Health Receives Key BGI COVID-19 Testing Equipment Honouring Internationally Renowned Canadian Physician Dr. Norman Bethune

  5/14/2020

  BGI announced that Sinai Health, a significant centre for COVID-19 testing in Canada, will receive a donation from The Mammoth Foundation of key laboratory equipment to increase its COVID-19 detection capability.

• Illumina Files Patent Infringement Suit Against BGI in Denmark

  5/15/2019

  Illumina filed suit in the Maritime & Commercial High Court of Denmark.

• MGI Announces Price and Early Access Customer of MGISEQ-T7

  1/9/2019

  Highest Throughput Sequencer Brings Power of Choice to the Market

• ESPERITE and BGI Genomics Sign a Strategic Agreement to Offer Whole Genome Sequencing on a Large Scale

  1/31/2018

  BGI has accepted to finance Esperite's access to the technology.

• BGI Increases Long-Read Sequencing Capacity With Purchase of 10 PacBio Sequel Systems

  1/25/2018

  This will significantly expand the capacity for Single Molecule, Real-Time Sequencing for BGI’s global sequencing service business, which currently operates two Sequel Systems and a PacBio RS II Sequencing System.

• MGI Genetic Sequencer Certified in New 10x Genomics Compatible Program

  1/8/2018

  10x Genomics, Inc. and MGI, a subsidiary of BGI, today announced that the BGISEQ-500RS genetic sequencer has met the rigorous standards of the new 10x Genomics Compatible Program.

• BGI's MGI Tech Launches Two New NGS Platforms

  10/31/2017

  MGI Tech launched two new next generation genetic sequencers, MGISEQ-2000 and MGISEQ-200, at the 12th International Conference on Genomics in Shenzhen.

• Week In Review: Shenzhen's BGI Plans $250 Million China IPO To Support Genomics Operations

  6/26/2017

• BGI's $250 Million Shenzhen IPO Scheduled For July

  6/20/2017

• BGI To Work With Broad Institute, Intel And Alibaba Cloud To Provide Free Access To GATK4 On BGI Online Platform

  5/25/2017

• China's BGI And Healthlink Invest And Make Deal With UK's Congenica

  4/28/2017

• Congenica Completes Series B Financing Round With Investments From China-Based BGI Healthlink And Future Planet

  4/27/2017

• Week In Review: BGI Plans $250 Million Shenzhen IPO

  3/20/2017

• BGI Re-Files To Raise $250 Million In Shenzhen IPO

  3/16/2017

• Dr. Leroy Hood Joins BGI Scientific Advisory Board

  3/13/2017

• BGI: The International Sc2.0 Project Is On Track To Build The World's First Synthetic Yeast Genome

  3/10/2017

• BGI Opens Seattle Office For North America Expansion

  12/14/2016

• Week In Review: Chi-Next Exchange Rejects BGI's $260 Million IPO Application

  11/7/2016

• BGI's Shenzhen IPO Rejected By China Regulators

  11/4/2016